Trinity Biotech (TRIB) EBT (2009 - 2024)
Trinity Biotech (TRIB) posted quarterly EBT of -$15.8 million for Q4 2024, down 186.96% year-on-year from $18.2 million in Q1 2024, and down 229.52% on a QoQ basis from -$4.8 million in Q3 2024.
Trinity Biotech (TRIB) EBT (2009 - 2024) Analysis & Trends
Trinity Biotech (TRIB) has reported EBT for 16 consecutive years, with -$15.8 million the latest figure, recorded in Q4 2024.
- Quarterly EBT fell 186.96% year-over-year to -$15.8 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$30.7 million (up 16.8% YoY) and the FY2025 annual result came in at -$37.2 million, down 20.98% from the prior year.
- EBT eased to -$15.8 million in Q4 2024 per TRIB's latest filing, from -$4.8 million in the prior quarter.
- Over the last five years, EBT for TRIB reached as high as $7.9 million in Q3 2020 and fell as low as -$18.6 million in Q2 2023.
- A 5-year average of -$5.5 million and a median of -$5.9 million in 2023 frame the typical range for EBT.
- Annual changes were most pronounced in 2020 — EBT soared 3631.28% — and 2022, when it slumped 7829.69%.
- Year by year, EBT stood at -$14.3 million in 2020, then jumped by 83.0% to -$2.4 million in 2021, then slumped by 329.53% to -$10.4 million in 2022, then surged by 47.21% to -$5.5 million in 2023, then sank by 186.96% to -$15.8 million in 2024.
- According to Business Quant data, EBT over the past three periods registered -$15.8 million, -$4.8 million, and -$6.9 million for Q4 2024, Q3 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.45 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 850.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.83 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.16 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 459.00 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 269.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 222.44 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 505.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Trinity Biotech | 93,750.00 | -5.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -15.80 Mn |
| Sep 30, 2024 | -4.79 Mn |
| Jun 30, 2024 | -6.89 Mn |
| Mar 31, 2024 | -3.25 Mn |
| Dec 31, 2023 | -5.51 Mn |
| Sep 30, 2023 | -6.50 Mn |
| Jun 30, 2023 | -18.61 Mn |
| Mar 31, 2023 | -6.32 Mn |
| Dec 31, 2022 | -10.43 Mn |
| Sep 30, 2022 | -9.99 Mn |
| Jun 30, 2022 | -10.15 Mn |
| Mar 31, 2022 | -13.22 Mn |
| Dec 31, 2021 | -2.43 Mn |
| Sep 30, 2021 | 1.60 Mn |
| Jun 30, 2021 | -128,000.00 |
| Mar 31, 2021 | 4.29 Mn |
| Dec 31, 2020 | -14.28 Mn |
| Sep 30, 2020 | 7.87 Mn |
| Jun 30, 2020 | 1.72 Mn |
| Mar 31, 2020 | 2.96 Mn |